Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Oncology
Management of Targeted Drug Resistance in NSCLC
Overview of Guideline Recommendations for Screening and Management of Lung Cancer
Immunotherapy for the Treatment of NSCLC
Immunomodulation of Checkpoints Resets Immune System in NSCLC
Molecular Testing in Lung Cancer Pathology
Downregulation of ERCC1 Boosts Efficacy of Platinum-Based NSCLC Chemotherapy
No Significant Difference in Treatment versus Supportive Care in Stage IV NSCLC
Paclitaxel plus Bevacizumab is a Feasible Option for Chemoresistant SCLC
Benefit and Tolerance to Induction Therapy in Elderly Patients with Locally Advanced NSCLC
Brain Metastases Safely Treated with WBRT after Bevacizumab and Chemotherapy in NSCLC
Pages
Previous
Next
1
…
4
5
6
7
8
9
10
11
12